Skip to content
Open access

Characterization of the circadian system in binge eating disorder and the effects of morning bright light and individually timed exogenous melatonin administration: A 4-week feasibility double-blind randomized controlled mechanistic clinical trial

Francisco Romo-Nava Helen J. Burgess Thomas Blom Xuan Cao Brady Williamson Georgi Georgiev Jakyb Stoddard Maya Goertemoeller John Fu Nicole Mori Christina Charnas Phong Phan Robert McNamara Jeffrey Welge Carlos M. Grilo Frank Scheer Susan L. McElroy
Aug 2026 · Research Square · 0 citations · 97 references
Medicine

Abstract

Introduction: Binge eating disorder (BED) exhibits features consistent with circadian system dysregulation. This two-phase study mechanistically examined BED chronobiology. We hypothesized that dim light melatonin onset (DLMO; circadian phase) is delayed in BED and associated with illness characteristics, and be modifiable via a chronobiotic intervention. Methods: Phase 1 (P1) was a 2-week observational study comparing adults with obesity with BED (n = 43) and without BED (controls, n = 41). Phase 2 (P2) was a 4-week double-blind, randomized, controlled pilot trial in BED (NCT04724668). Participants received morning bright light (BLT; 10,000 lx) plus individually timed exogenous melatonin (3 mg) administration (BLT+ITEMA, n = 13) or sham red light (50 lx) plus placebo (n = 10). Primary outcomes were baseline DLMO differences (P1) and DLMO change (P2). Secondary/exploratory measures included wrist actigraphy and clinical features. ANCOVA, correlation, and Bayesian methods were used for statistical analysis. Results: In P1, DLMO did not differ between groups, but later DLMO correlated with greater BED severity. BED participants showed lower 24-hour locomotor amplitude and MESOR (both, posterior probability [pp] = 1), poorer diet quality, higher night eating and leptin levels (all p < 0.05). In P2, DLMO change did not differ between groups. Compared to sham+placebo, BLT+ITEMA participants had smaller reductions in peak activity (pp = 0.97) and amplitude (pp = 0.87), plus increased dietary restraint and LcN-3 fatty acids (both p < 0.05). Later baseline DLMO correlated with greater phase advance and binge eating reduction (both p < 0.05). The intervention was well tolerated. Conclusions: A later circadian phase correlated with greater BED severity, and dampened actigraphy rhythms, both support circadian disruption in BED. The mechanistic intervention is feasible and warrants refinement.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.